Premium
Blonanserin in the treatment of delirium
Author(s) -
Kato Koji,
Yamada Keigo,
Maehara Mizuki,
Akama Fumiaki,
Kimoto Keitaro,
Saito Mai,
Yano Hiroshi,
Ichimura Atsushi,
Matsumoto Hideo
Publication year - 2011
Publication title -
psychiatry and clinical neurosciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.609
H-Index - 74
eISSN - 1440-1819
pISSN - 1323-1316
DOI - 10.1111/j.1440-1819.2011.02213.x
Subject(s) - delirium , intensive care unit , medicine , emergency medicine , anesthesia , intensive care medicine
The purpose of the present study was to provide preliminary data on the usefulness and safety of blonanserin for patients with delirium in the intensive care unit (ICU). The charts of 32 consecutive patients with delirium in the ICU were retrospectively reviewed. These patients were treated with blonanserin. A total of 96.6% had reduction in Memorial Delirium Assessment Scale score. The proportion of patients with side‐effects was 24.1%. Blonanserin may be effective and safe in the treatment of delirium in the ICU.